Differential responses of the right ventricle to abnormal loading conditions in vivo: Possible pathophysiologic mechanisms

Journal of Thoracic and Cardiovascular Surgery

Volumn 145, Issue 5, 2013, Pages 1335-1344

  Azakie, Anthony ^a   Fineman, Jeffrey ^a   He, Youping ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN; MYOCYTE ENHANCER FACTOR 2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTOPULMONARY SHUNT; ARTICLE; CARDIOVASCULAR RESPONSE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DENSITOMETRY; DROSOPHILA; FETUS; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HEART FAILURE; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART WORK; HEMODYNAMIC PARAMETERS; IMMUNOPRECIPITATION; IN VIVO STUDY; INSECT CELL CULTURE; LAMB; LUNG ARTERY BANDING; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; SARCOMERE; TRANSACTIVATION; WESTERN BLOTTING;

ACETYLATION; ANIMALS; BINDING SITES; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DISEASE MODELS, ANIMAL; FEMALE; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HEART VENTRICLES; HEMODYNAMICS; HYPERTROPHY, RIGHT VENTRICULAR; MYOCARDIUM; MYOGENIC REGULATORY FACTORS; PREGNANCY; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; PULMONARY ARTERY; SHEEP; SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 84876411746     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.01.016     Document Type: Article

References (17)

1. K.R. Chien Stress pathways and heart failure Cell 98 1999 555 558
2. J.J. Hunter, and K.R. Chien Signaling pathways for cardiac hypertrophy and failure N Engl J Med 341 1999 1276 1283
3. A. Azakie, J.R. Fineman, and Y. He Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo J Thorac Cardiovasc Surg 132 2006 1262 1271
4. A. Azakie, J.R. Fineman, and Y. He Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivo Am J Physiol Heart Circ Physiol 291 2006 H600 H611
5. T.A. McKinsey, and E.N. Olson Cardiac histone acetylation: therapeutic opportunities abound Trends Genet 20 2004 206 213
6. T.A. McKinsey, and E.N. Olson Toward transcriptional therapies for the failing heart: chemical screens to modulate genes J Clin Invest 115 2005 538 546
7. E.N. Olson, J. Backs, and T.A. McKinsey Control of cardiac hypertrophy and heart failure by histone acetylation/deacetylation Novartis Found Symp 274 2006 3 12 discussion 13-9, 152-5, 272-6
8. T.A. McKinsey Therapeutic potential for HDAC inhibitors in the heart Annu Rev Pharmacol Toxicol 52 2012 303 319
9. B. Bartelds, M.A. Borgdorff, A. Smit-van Oosten, J. Takens, B. Boersma, and M.G. Nederhoff Differential responses of the right ventricle to abnormal loading conditions in mice: pressure vs. volume load Eur J Heart Fail 13 2011 1275 1282
10. V.M. Reddy, B. Meyrick, J. Wong, A. Khoor, J.R. Liddicoat, and F.L. Hanley In utero placement of aortopulmonary shunts: a model of postnatal pulmonary hypertension with increased pulmonary blood flow in lambs Circulation 92 1995 606 613
11. H. Braun, R. Koop, A. Ertmer, S. Nacht, and G. Suske Transcription factor Sp3 is regulated by acetylation Nucl Acids Res 29 2001 4994 5000
12. S. Ammanamanchi, J.W. Freeman, and M.G. Brattain Acetylated sp3 is a transcriptional activator J Biol Chem 278 2003 35775 35780
13. N. Schnur, S. Seuter, C. Katryniok, O. Radmark, and D. Steinhilber The histone deacetylase inhibitor trichostatin A mediates upregulation of 5-lipoxygenase promoter activity by recruitment of Sp1 to distinct GC-boxes Biochim Biophys Acta 1771 2007 1271 1282
14. M.J. Nunes, I. Milagre, M. Schnekenburger, M.J. Gama, M. Diederich, and E. Rodrigues Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression of CYP46A1 gene transcription J Neurochem 113 2010 418 431
15. Y. Sowa, T. Orita, S. Minamikawa-Hiranabe, T. Mizuno, H. Nomura, and T. Sakai Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor Cancer Res 59 1999 4266 4270
16. H. Chirakkal, S.H. Leech, K.E. Brookes, A.L. Prais, J.S. Waby, and B.M. Corfe Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding Oncogene 25 2006 7192 7200
17. P.R. Kiela, N. Kuscuoglu, A.J. Midura, M.T. Midura-Kiela, C.B. Larmonier, and M. Lipko Molecular mechanism of rat NHE3 gene promoter regulation by sodium butyrate Am J Physiol Cell Physiol 293 2007 C64 C74